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Summary
Cell-cell fusion initiates fertilization, sculpts tissues
during animal development, reprograms stem cells to
new differentiated states, and may be a key step in
cancer progression. While cell fusion is tightly regu-
lated, the mechanisms that limit fusion to appropriate
partners are unknown. Here, we report that the fus-1
gene is essential to repress fusion of epidermal cells
in C. elegans: in severe fus-1 mutants, all epidermal
cells, except the lateral seam cells, inappropriately
fuse into a single large syncytium. This hyperfusion
requires EFF-1, an integral membrane protein essen-
tial for fusion of epidermal cells into discrete syncy-
tia. FUS-1 is localized to the apical plasma membrane
in all epidermal cells potentiated to undergo fusion,
whereas it is virtually undetectable in nonfusing seam
cells. fus-1 encodes the e subunit of the vacuolar H+-
ATPase (V-ATPase), and loss of other V-ATPase sub-
units also causes widespread hyperfusion. These
findings raise the possibility of manipulating cell fu-
sion by altering V-ATPase activity.
Introduction
Fusion of lipid bilayers between cells to create a single
multinucleate cell not only marks the beginning of life
for most multicellular organisms, but also features
prominently in the subsequent formation of tissues and
organs (Bischof et al., 2000; Dworak and Sink, 2002;
Shemer and Podbilewicz, 2003; Wassarman et al.,
2001; Witze and Rothman, 2002). During normal devel-
opment, the fusion of myoblasts to form myotubes, tro-
phoblasts to form the placental syncytium, and mono-
cytes to form osteoclasts is pivotal to the genesis of
muscle, placenta, and bone, respectively. Recent find-
ings indicate that cell fusion may also underlie stem cell
plasticity: bone marrow stem cells can be repro-
grammed into multiple differentiated cell types, includ-
ing hepatocytes, cardiocytes, and neural cells, by cell
fusion (Wagers and Weissman, 2004). Mounting evi-*Correspondence: rothman@lifesci.ucsb.edu
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ogy, Children’s Hospital, Boston, Massachusetts 02115.dence suggests that inappropriate cell fusion contrib-
utes to cancer progression: various tumor cell types are
fusogenic, and promiscuous fusion between tumor
cells or between tumorigenic and normal cells can en-
dow hybrids with new properties such as higher prolif-
eration rates, metastasis, and resistance to apoptosis
and drugs (Duelli and Lazebnik, 2003). Thus, the fuso-
genicity of tumor cells can increase tumor cell diversity,
thereby enhancing their malignancy.
Fusion is a tightly regulated process normally re-
stricted to only subsets of cells. While it is clear that
the fusion machinery must be judiciously regulated to
ensure that cells do not inappropriately fuse with their
neighbors, the mechanisms that regulate this specific-
ity are not understood. During C. elegans development,
about one-third of somatic cells undergo a set of fu-
sions to form an invariant pattern of syncytia (Podbi-
lewicz and White, 1994; Shemer and Podbilewicz,
2003). This stereotyped cell fusion program is highly
regulated, and even the particular side of a cell that
fuses is highly reproducible. Extensive genetic screens
have identified many alleles of a single gene, eff-1, that
is essential for fusion: in eff-1 mutants, all epidermal
cells fail to fuse (Mohler et al., 2002; B. Podbilewicz and
W. Mohler, personal communication). EFF-1 is a trans-
membrane protein with a sequence motif similar to
those known to promote fusion of lipid bilayers and is
therefore likely to be part of the machinery that medi-
ates cell fusion. Although several transcription factors
and signaling pathways are known to regulate cell fu-
sion events and eff-1 expression (Alper and Kenyon,
2002; Chen and Han, 2001; Koh and Rothman, 2001;
Shemer and Podbilewicz, 2002), it is not known how
the fusogenic action of EFF-1 is restricted to particular
sets of cells to create many distinct and adjacent syn-
cytia.
Results and Discussion
To investigate the molecular mechanisms that limit cell-
cell fusion to the appropriate cells, we have identified
genes required for normal cell-fusion patterns in C. ele-
gans. Most cell fusion in C. elegans embryos occurs in
the epidermis during body elongation. The epidermis is
an epithelial sheet that is subdivided into pairs of dor-
sal, lateral, and ventral rows of cells (Priess and Hirsh,
1986). The anterior, dorsal, and ventral cells undergo
limited, specific fusions to generate several distinct and
stably maintained syncytia (Figure 1A). Neither P cells,
the central cells in the ventral row, nor seam cells, the
lateral cells, fuse during embryogenesis. The pattern of
cell fusion can be monitored by following AJM-1, a pro-
tein of the apical junctions surrounding each epithelial
cell (Alper and Kenyon, 2002; Koh and Rothman, 2001;
Koppen et al., 2001; Mohler et al., 1998; Mohler et al.,
2002; Podbilewicz and White, 1994). Fusion of two cells
results in elimination of the AJM-1 boundary between
them, while AJM-1 stably demarcates the boundary be-
tween adjacent syncytia.
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(A) The fusion of epidermal cells, occurring between the “comma” stage (w6.5 hr pf; left) and 2-fold stage (w7.5 hr pf; right) of normal
embryonic development, is revealed by the pattern of apical junctions outlining each of these cells, as schematized. The positions of three
(hyp5-hyp7) of the eleven epidermal syncytia are indicated.
(B–F) Immunostaining of embryos with AJM-1 reactive monoclonal antibody, MH27, to visualize cell boundaries in the epidermis. In all panels,
the same seam cell is indicated by an asterisk and the first two ventral P cells are numbered when they have not undergone complete fusion.
(B) Wild-type embryo (w1.5-fold stage). Cell boundaries between hyp5 and hyp6 (arrowheads) and between hyp6 and hyp7 (arrows) are
visible.
(C–G) eDf18 arrested embryo showing the hyperfusion phenotype. The hyp5/hyp6 and hyp6/hyp7 boundaries and some of the ventral P cell
boundaries are absent as a result of hyperfusion. Hyperfusion phenotypes of embryos were classified into five groups (G) on the basis of
ectopic cell fusions (closed circle, severe hyperfusion; closed triangle, mild hyperfusion; open circle, no hyperfusion) in two major regions of
the epidermis (hyp5/hyp6/hyp7 and ventral P cells) as described in the Experimental Procedures. (D) Class I (in which all except seam
epidermal cells fuse to form a large syncytium), (E) Class II, and (F) Class III fus-1 embryos are shown.
(H and I) Quantitative analysis of the hyperfusion phenotype of eDf18 and fus-1 embryos based on the classification described above.
Scale bars equal approximately 10 m.Previous screens in our lab and others have identified t
sseveral chromosomal deficiencies in which epidermal
cells apparently undergo hyperfusion (Labouesse, 1997; u
pTerns et al., 1997). A particularly striking hyperfusion
phenotype is observed with the deficiency eDf18, a
which deletes a segment of chromosome IV: in terminal
eDf18 embryos, most of the boundaries of the anterior, i
cdorsal, and ventral epidermal cells disappear, revealing
the hyperfusion phenotype (Figure 1C); however, the f
tseam cell boundaries persist, such that in many eDf18
embryos, AJM-1 delimits only a chain of ten cells on t
ieach side.
We isolated a recessive zygotic lethal mutation in a c
hgene we have called fus-1 by screening for lethal muta-
tions targeted to the region defined by eDf18. In fus- t
c1(w13) mutant embryos, most of the epidermal cells
that normally contribute to the 11 hyp cells (hyp1-11) 2
eundergo hyperfusion (Figures 1D–1F). In the most se-
verely affected fus-1 embryos, all epidermal cells ex- d
icept the seam cells fuse into a single, large syncytium
(Figure 1D). The AJM-1 staining patterns of other epi- s
othelia, including those of the pharynx and intestine, ap-
pear to be unaffected in fus-1 mutant (data not shown). c
Semiquantitative analysis of the hyperfusion pheno-ypes revealed that the expressivity of hyperfusion is
omewhat stronger for eDf18 than for fus-1(w13) (Fig-
res 1H and 1I), suggesting that fus-1(w13) may be a
artial loss-of-function mutant or that eDf18 deletes
dditional gene(s) required for proper cell fusion.
To assess the dynamics of inappropriate cell fusion
n fus-1(w13) embryos, we followed time-dependent
hanges in the AJM-1 staining pattern (Figures 2A–2H).
us-1 homozygous embryos arrest in morphogenesis at
he 2- to 2.5-fold stage (w8 hr postfertilization, pf). At
his time, embryos initially show a normal AJM-1 stain-
ng pattern (Figures 2A and 2B). Hyperfusion becomes
onspicuous at around the time that embryos normally
atch (w15 hr pf) (Figures 2C and 2D), and the propor-
ion of embryos with the hyperfusion phenotype in-
reases progressively until w24 hr pf (Figures 2G and
H). These observations suggest that fus-1 is not
ssential for the initial pattern of cell fusions in the epi-
ermis and that the hyperfusion phenotype arises from
nappropriate activation of the cell fusion program per
e in late-stage embryos, rather than as a consequence
f abnormal patterning or specification of epidermal
ells during early embryogenesis.
To examine further whether the hyperfusion observed
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789Figure 2. Time Course of fus-1 Hyperfusion and Suppression by eff-1 Mutations
Embryos were collected at various times (A, C, E, G, I, K, M) and immunostained with MH27 antibody. The same seam cell is indicated by an
asterisk. Hyperfusion was quantified as described in the Experimental Procedures and the results are shown on the right of each micrograph
(B, D, F, H, J, L, N). Time points were w9 hr pf (A, B), w15 hr pf (C, D), w20 hr pf (E, F), and w24 hr pf (G–N). The hyperfusion phenotype of
fus-1 is strongly suppressed by eff-1mutations: fus-1(w13) (I, J), eff-1(hy21); fus-1(w13) (K, L), and eff-1(oj55); fus-1(w13) (M, N). IV/V indicates
that a low-level fusion was observed (it is not known if such fusion occurs in the normally fusing cells or ectopically, hence it is not possible
to categorize these into class IV or V). NF, no fusion observed, as is typical for eff-1 mutants. Scale bars equal approximately 10 m.in fus-1mutants results from inappropriate activation of
the normal cell fusion program, we examined whether it
requires eff-1, the only gene known to be essential for
all epidermal cell fusions in C. elegans. Indeed, we
found that hyperfusion in fus-1(w13) and eDf18 homo-
zygous embryos is strongly suppressed by two dif-
ferent mutations in eff-1 (Figures 2I–2N and data not
shown). This epistasis of eff-1 to fus-1 indicates that
hyperfusion in fus-1 mutants does not simply reflect
nonspecific fusion of lipid bilayers, but instead occurs
by an EFF-1-directed process. In eff-1 mutants, all epi-
dermal cells fail to fuse during embryogenesis; how-
ever, a minor fraction of epidermal cells fuse in eff-
1;fus-1 double mutants (Figures 2L and 2N). While it is
conceivable that some eff-1-independent cell fusion
may occur in the fus-1mutant, the eff-1mutations used
here are not null (Mohler et al., 2002; B. Podbilewicz,
personal communication), and it may be that a much
smaller activity of eff-1 is sufficient to induce cell fusion
in fus-1(-)mutants than in wild-type. Although eff-1mu-
tations suppress hyperfusion in fus-1 mutants, they do
not suppress its embryonic lethality (data not shown),
implying that hyperfusion is not the exclusive cause of
the embryonic lethality.
We identified the fus-1 gene molecularly by standard
positional cloning and rescue experiments (Figure 3A).
A genomic fragment encompassing the predicted gene
F49C12.13 efficiently rescues both the hyperfusion and
embryonic lethality of the fus-1(w13) mutant. The w13
allele carries a G to A transition at the consensus
splice-acceptor site of the third exon in F49C12.13.Analysis of a cDNA of this gene prepared from fus-1
homozygotes revealed that the w13 mutation results in
a misspliced transcript; the use of a new acceptor site
results in a premature stop codon in the predicted
translation product (Figure 3B). RNAi of F49C12.13 re-
sults in hyperfusion of the epidermal cells that is sup-
pressed by the eff-1 mutation (Figure 3E and data not
shown).
The predicted FUS-1 protein shows significant sim-
ilarity to the vacuolar H+-ATPase (V-ATPase) e subunit
from other species. The V-ATPases are multisubunit
proton pumps composed of two functional sectors, V1
and V0 (Nishi and Forgac, 2002; Stevens and Forgac,
1997): a peripheral membrane V1 domain is responsible
for ATP hydrolysis, which drives proton transport
through an integral membrane V0 domain (Figure 3D).
The V-ATPase e subunit is a highly hydrophobic protein
with two putative transmembrane domains. While the
function of the V-ATPase e subunit remains unknown,
recent studies have suggested that Vma9p, the e sub-
unit of the yeast S. cerevisiae, is a functionally essential
part of the V-ATPase and is involved in assembly of the
V-ATPase complex (Davis-Kaplan et al., 2004; Sambade
and Kane, 2004). Sequence alignments of the human,
Drosophila melanogaster, and C. elegans proteins re-
veal high similarity in their carboxy-terminal (C-ter-
minal) regions, immediately following the second trans-
membrane domain (Figure 3C). We confirmed the
importance of the C-terminal region in rescue experi-
ments using wild-type and C-terminal-deleted con-
structs of FUS-1: while the wild-type fus-1 efficiently
Developmental Cell
790Figure 3. Molecular Characterization of fus-1 and Induction of Hyperfusion by RNAi of Other V-ATPase Subunits
(A) Positional cloning of fus-1. The w13 mutation maps between two SNPs (arrowheads) on chromosome IV and is not complemented by
eDf18. Among four overlapping cosmid clones covering the mapped genomic region, only F49C12 is able to rescue the fus-1 phenotype. An
F49C12-derived genomic fragment encompassing the predicted gene F49C12.13 rescues the fus-1 phenotype. The position of the w13
mutation in F49C12.13 is indicated with a vertical arrow. Plasmid constructs containing wild-type F49C12.13 (pkk-WT) and a deletion mutant
of the gene (pkk-C35) were used in rescue experiments. The number of rescued transgenic lines out of the total number of lines scored is
indicated at the right of each construct tested.
(B) Sequence analysis of cDNAs prepared from fus-1 homozygous embryos showed that the w13 mutation results in a misspliced transcript
containing a premature stop codon, resulting from the use of a new splice acceptor site.
(C) ClustalW sequence alignment of the human V-ATPase e subunit (GenBank accession number Y15286), Drosophila melanogaster VhaM9.7-1
(accession number NM_139611) and C. elegans FUS-1. Two putative transmembrane domains (TM1 and TM2) predicted by the SOSUI
program (http://sosui.proteome.bio.tuat.ac.jp/sosuiframe0.html) are indicated with a line.
(D) Schematic of V-ATPase subunits (modified from Nishi and Forgac, 2002). The peripheral (V1) and integral (V0) membrane sectors are
represented by white and gray, respectively.
(E) MH27 staining of a terminal F49C12.13 (RNAi) embryo, in which the hyperfusion phenotype of fus-1(w13) embryos is phenocopied with a
penetrance of w20%. The strongly affected embryos arrest at early stages with a variable undifferentiated morphology, suggesting that
maternal contribution of FUS-1 is required for early embryogenesis. Scale bar equals approximately 10 m.
(F and G) MH27 staining of vha-1(RNAi) (F) and vha-12(RNAi) (G) embryos also reveals a hyperfusion phenotype with w20% penetrance in
both cases, similar to the results with fus-1(RNAi).rescues the fus-1 phenotype, the deletion mutant (pkk- g
nC35, carboxyl 35 amino acid deletion) does not (Fig-
ure 3A). Moreover, the w13 allele apparently results in s
1a C-terminally deleted protein (Figure 3B), further un-
derscoring the importance of this domain. b
aAlthough the inappropriate fusion in fus-1 mutants
requires EFF-1 activity, this hyperfusion could be a se- l
rcondary consequence of the embryonic lethality; for
example, inappropriate cell fusion might result from de- Ieneration of dying embryos. However, of the large
umber of embryonic lethal mutants studied, very few
how hyperfusion (e.g., Labouesse, 1997; Terns et al.,
997; J.H.R., unpublished observation), and most em-
ryonic lethal mutants known to undergo hyperfusion
re defective in components of the V-ATPase (see be-
ow). Thus, it is clear that embryonic lethality and deg-
adation per se does not generally lead to cell fusion.
n an effort to separate the hyperfusion phenotype of
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791the fus-1mutation from embryonic lethality or degrada-
tion, we assayed for inappropriate cell fusion in living
larvae that escaped the embryonic lethality of the fus-
1(w13) mutation, but which contained subnormal levels
of FUS-1. We found that a substantial fraction of fus-1
homozygotes rescued for embryonic lethality with a
fus-1 genomic fragment that is expressed at low levels
undergo inappropriate epidermal cell fusion (Supple-
mental Figure S1): while postembryonic cell fusion at
the boundary between hyp6 and hyp7 is normally sup-
pressed until the mid-L2 stage in wild-type animals
(Yochem et al., 1998), these cells inappropriately fuse
during the early L1 stage (no later than 5 hr after hatch-
ing) in the rescued fus-1 homozygotes. Thus, fus-1 is
not only required to inhibit fusion of cells in the embryo
that normally never fuse, as described above, but it is
also necessary to repress fusion of cells that normally
do undergo fusion later in development. This premature
fusion was seen in larvae that by Nomarski microscopy
appeared healthy and showed no signs of necrosis or
deterioration (e.g., Supplemental Figure S1). Moreover,
while this weakly expressed fus-1 transgene is insuffi-
cient to rescue the mutants to adulthood, the larvae
remained alive for at least 3 days after the time at which
this precocious fusion was observed. Although we can-
not rule out the possibility that inappropriate cell fusion
in fus-1-arrested embryos is a consequence of the em-
bryonic lethality, these observations suggest that fus-1
is required to repress cell fusion during development.
To address whether FUS-1 is sufficient to prevent cell
fusion, we expressed it from a heat shock driven con-
struct and found that its overexpression alone does not
suppress epidermal cell fusion (not shown). However,
FUS-1 overexpression did not increase the levels of at
least one other V-ATPase subunit (not shown); thus, as-
sessing whether elevated expression of the V-ATPase
is sufficient to prevent cell fusion might require overex-
pressing the entire V-ATPase, which consists of at least
13 subunits.
The localization of FUS-1 supports a role for its ac-
tion at the plasma membrane in cells that are potenti-
ated to fuse. Anti-FUS-1 antibody first detects FUS-1
in a punctate pattern within the gut cells of embryos at
approximately the comma stage (w6 hr pf); it is unde-
tectable in epidermal cells at this early stage (Figures
4B and 4E). FUS-1 is also detected in the excretory cell
(Figure 4K) and the apical membrane of gut cells (not
shown) starting later in embryogenesis. In the epider-
mis, the protein is first conspicuously detected in 2-fold
stage embryos shortly after most epidermal cell fusions
occur (data not shown). Initially, FUS-1 expression is
seen at approximately equal levels throughout the dor-
sal, ventral, and anterior epidermal cells (not shown); it
is specifically excluded from the lateral seam cells. As
the embryo develops, FUS-1 levels increase in these
epidermal cells, where it concentrates almost exclu-
sively on the apical membrane (Figures 4H and 4K) and
some colocalizes with apical junctions (Figures 4L–4N).
FUS-1 remains virtually undetectable in seam cells (Fig-
ure 4H), which neither fuse in wild-type embryos and
fus-1 mutants nor express EFF-1. Thus, all cells that
inappropriately fuse in fus-1 mutants express eff-1,
consistent with the epistasis results. Together with the
finding that eff-1-mediated hyperfusion occurs in ante-rior, dorsal, and ventral epidermal cells in fus-1(-) em-
bryos, it is therefore likely that FUS-1 functions as a
suppressor of EFF-1-dependent cell fusion in these
cells. The localization of FUS-1 at the plasma mem-
brane of epidermal cells raises the possibility that it
might do so by directly acting on EFF-1, also an appar-
ent cell surface protein (W. Mohler, personal communi-
cation).
The identification of FUS-1 as the e subunit of the
V-ATPase motivated us to investigate whether the loss
of other V-ATPase subunits (Oka and Futai, 2000; Oka
et al., 2001) affects cell fusion. We performed RNAi ex-
periments against vha-1 and vha-12, which encode the
C. elegans homologs of the c and B subunits of the
V-ATPase, respectively. As shown in Figures 3F and 3G,
vha-1(RNAi) and vha-12(RNAi) embryos show a hyper-
fusion phenotype that is indistinguishable from that of
the fus-1 mutant on the basis of the AJM-1 staining
pattern. In both cases, the hyperfusion phenotype was
suppressed by an eff-1 mutation (not shown). These
results suggest that the V-ATPase complex functions
as a negative regulator of eff-1-mediated cell fusion in
the C. elegans embryo. Screens of chromosomal defici-
encies have revealed several loci that result in inappro-
priate fusion of epidermal cells (Labouesse, 1997; Terns
et al., 1997). Genetic mapping data shows that most
of these deficiencies delete genes encoding V-ATPase
subunits (not shown), suggesting that the genes re-
sponsible for the hyperfusion phenotype of these defi-
ciencies are likely to encode V-ATPase subunits.
How might components of the V-ATPase, or perhaps
the entire complex, repress EFF-1-mediated cell fu-
sion? EFF-1 is the only protein known to be essential
for all epidermal cell fusions, and its forced expression
is sufficient to promote fusion of cells that normally do
not fuse (Shemer et al., 2004). Negative regulation of
eff-1 transcription is known to be important for C. ele-
gans development: for example, eff-1 is transcription-
ally repressed to prevent inappropriate fusion of seam
cells (Mohler et al., 2002) and the precursor cells that
divide to give rise to the vulva postembryonically
(Shemer and Podbilewicz, 2002). To examine possible
transcriptional effects of FUS-1 on eff-1, we analyzed
the expression of an eff-1 transcriptional reporter con-
struct and found that both the patterns and levels of
eff-1 are unaffected by a fus-1 mutation (not shown).
eff-1 is expressed not only in fusion-competent epider-
mal cells but also in some ventral epidermal cells that
normally never fuse during embryogenesis (Mohler et
al., 2002). Thus, repression of fusion in cells expressing
the fusogenic EFF-1 protein must involve inhibition of
its activity. We have shown that FUS-1 concentrates at
the apical membrane of these EFF-1-expressing epi-
dermal cells and that V-ATPase subunits are essential
to prevent inappropriate fusion of the epidermal cells;
thus, the V-ATPase performs a critical function in re-
stricting cell fusion by EFF-1 in the epidermis.
Given that cell fusion is known to initiate at a site
along the apical edge of the fusing border and pro-
gresses basally (Mohler et al., 1998) and that the e sub-
unit of V-ATPase has also been shown to be localized
in the apical membrane of epidermal cells (Choi et al.,
2003), it is reasonable to suppose that the V-ATPase
components may act in the plasma membrane to re-
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792Figure 4. FUS-1 Localizes to the Apical
Membrane of Epidermal Cells in Late-Stage
Embryos
(A–L) Images of wild-type embryos stained
with MH27 (A, D, G, J), anti-FUS-1 (B, E, H,
K), and the merge of both (C, F, I, L). External
(A–C) and internal (D–F) focal planes of
w1.5-fold embryo show no detectable FUS-
1 in the epidermis (B) and punctate staining
in gut cells (E). Surface (G–I) confocal images
of a w3-fold embryo shows FUS-1 localized
to the apical surface of dorsal and ventral
epidermal cells, with virtually no staining de-
tected in seam cells (H). FUS-1 is also ob-
served in the excretory cell (arrow in K), as
seen in an internal (J–L) focal plane of the
same embryo.
(M and N) Enlarged images of the region
shown in the white rectangles in (L). Magni-
fied images of the area around the apical
junctions between hyp6 and hyp7 (M) and
between the P1 and P2 cells (N) show that
FUS-1 is localized to apical membranes of
the epidermal cells and partially colocalizes
with AJM-1. Scale bar equals approximately
10 m.press EFF-1-mediated membrane fusion. Extracellular d
Vacidification by plasma membrane V-ATPases is impor-
tant for a number of cell-surface processes (Nishi and t
rForgac, 2002; Stevens and Forgac, 1997) (e.g., bone
resorption); the fusion-promoting activity of EFF-1 may a
Sbe suppressed by local extracellular acidification cata-
lyzed by the plasma membrane-localized V-ATPase. Al- i
aternatively, subunits of the ATPase might directly
repress fusion by an acidification-independent mecha- c
2nism. Such a possibility is bolstered by findings that
implicate the V-ATPase directly in a membrane fusion i
Vevent: a trans-complex between V0 domains of adja-
cent intracellular yeast vacuole membranes promotes
ttheir fusion (Bayer et al., 2003; Peters et al., 2001). How-
ever, in this intracellular fusion process, the V-ATPase V
pactivates membrane fusion in contrast to its repressive
role in cell-cell fusion reported here. A possible resolu- f
ation for this apparent paradox may be that the mem-
brane topology of the V-ATPase is reversed relative to V
tthe membrane faces that initiate fusion in these twoistinct membrane fusion processes. Alternatively, the
-ATPase may be required to restrict EFF-1 localization
o regions of cell fusion. V-ATPases play an important
ole in various membrane transport, protein sorting,
nd degradation processes (Nishi and Forgac, 2002;
tevens and Forgac, 1997). A recent report shows that
nhibition of the V-ATPase prevents the degradation of
membrane type 1 matrix metalloproteinase and in-
reases its activity at the cell surface (Maquoi et al.,
003). It is thus possible that EFF-1 is mislocalized to
nappropriate cell membranes in the absence of
-ATPase function, leading to ectopic cell fusion.
Finally, our findings suggest that it may be possible
o intervene in cell fusion in vivo by modulating
-ATPase activity, perhaps by exploiting a variety of
harmacological agents known to affect V-ATPase
unction. For example, bone marrow stem cells can
dopt new fates by fusing with other cells; manipulating
-ATPase might enhance the fusion of stem cells,
hereby promoting their differentiation. Alternatively, the
V-ATPase as a Negative Regulator of Cell Fusion
793cell fusion-dependent steps in cancer progression
might be inhibited by elevating the levels or activity of
V-ATPase. If V-ATPase acts generally to repress cell fu-
sion, modulating the V-ATPase could provide a mecha-
nism for enhancing or preventing fertility.
Experimental Procedures
Classification of Embryonic Hyperfusion Phenotypes
Embryos were immunostained with monoclonal antibody MH27 to
visualize cell boundaries (see Supplemental Experimental Pro-
cedures), and cell fusion patterns were classified based on the ex-
tent of ectopic cell fusion in a defined region of the epidermis: se-
vere hyperfusion, most (>80%) epidermal cells ectopically fuse;
mild hyperfusion, some epidermal cells (at least two adjacent cells)
ectopically fuse; no hyperfusion, no epidermal cells ectopically
fuse (i.e., wild-type cell fusion pattern). Hyperfusion phenotypes
were then classified into five groups on the basis of the cell-fusion
patterns in the two major regions of the epidermis (hyp5/hyp6/hyp7
and ventral P cells), as defined in Figure 1G.
Strains and Genetics, Molecular Identification of fus-1, RNAi
Experiments, and Antibody Preparation and Immunostaining
See Supplemental Experimental Procedures.
Supplemental Data
Supplemental Data include one figure and Supplemental Experi-
mental Procedures and can be found with this article online at
http://www.developmentalcell.com/cgi/content/full/8/5/787/DC1/.
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